Navigation Links
First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals' Lead Therapeutic Candidate for Treatment of Migraine, ALD403
Date:3/20/2013

BOTHELL, Wash., March 20, 2013 /PRNewswire/ -- Alder Biopharmaceuticals Inc. today announced the dosing of the first patients in a proof-of-concept Phase 2 clinical study of its antibody therapeutic candidate, ALD403, targeting calcitonin gene-related peptide (CGRP) for treatment of migraine.

The double-blind, placebo-controlled, randomized study will evaluate the safety and efficacy of ALD403 administered monthly. One hundred and sixty patients with frequent, episodic migraines will be enrolled in the study across six sites for six months. Patients in the study will have experienced between four and 14 migraines per month in at least three months prior to enrollment and take acute migraine medication.

"Despite the enormous progress made in acute treatments for migraine, substantial unmet needs remain for patients experiencing multiple migraines per month," said Richard Lipton , M.D., principal investigator, professor of neurology and epidemiology at Albert Einstein College of Medicine in Bronx, New York, and director of the Montefiore Headache Center. "Most currently available preventive treatments for migraine are taken on a daily basis, reduce migraine frequency by 50 percent in about half of users and often produce significant side effects.  A biologic targeting CGRP and offering higher rates of efficacy, along with less frequent dosing and fewer side effects, could have a tremendous benefit for patients." 

Added Randall Schatzman , Ph.D., president and chief executive officer of Alder Biopharmaceuticals, "Alder is changing the paradigm for the treatment of migraine from abortive care at the time of migraine onset to a preventative approach, and our team has developed a highly specific therapeutic candidate with the potential to prevent the disorder before it begins that we believe has the ability
'/>"/>

SOURCE Alder Biopharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
2. Wyckoff Heights Medical Center Is First New York Hospital to Offer Asthmapolis Mobile Asthma Management Program
3. Quest Diagnostics Launches Dementia Diagnostic Panel, First in Industry for Treatable Forms of Cognitive Impairment Based on Medical Guidelines
4. ROX Medical enrolls first UK patients in CONTROL-HTN hypertension trial at Eastbourne General Hospital
5. Maddak Inc. Opens Possibilities For Disability Community With Launch Of Morph Wheels, First-Ever Foldable Wheelchair Wheels
6. N30 Pharmaceuticals Announces First Patient Treated in Clinical Trial of N6022 in Cystic Fibrosis
7. ISASS13 Shows Growth in New Exhibitors and First-Time Attendees
8. First Product in Tris Pharmas Collaboration with Vernalis Achieves Proof-of-Concept, Triggering Milestone Payment to Tris
9. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
10. UPDATE: Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
11. Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... a third of reproductive-aged women enrolled in Medicaid, and more ... prescription for an opioid pain medication each year during 2008-2012, ... Weekly Report (MMWR). Opioids are typically prescribed ... They are also found in some prescription cough medications. The ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... LAS VEGAS , Jan. 23, 2015 Cord Blood ... CBAI ) ("CBAI" or the "Company")  filed a Preliminary Proxy ... ( www.sec.gov ) today, and provides an update for shareholders ... authorized shares is requested. Dear Shareholders, ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... , GENEVA, Switzerland, December 14 ... Meeting was held,in Bermuda on 7th December. In excess of ... and overwhelmingly approved all the resolutions,put forward. , ... Shortt of Galmoy,as the new Director of Corporate Communications. In ...
... , , STUART, ... LBMH) is pleased to announce the addition of Mr. Joseph Farish ... Farish is s graduate of the University of Florida (Bachelor of ... has been a member of the Florida Bar for more than ...
Cached Medicine Technology:Calcitech Holds Annual General Meeting 2Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 2Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 3Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 4
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... January 22, 2015 Carinsurancesavings.biz has released a ... death and dismemberment insurance . , Purchasing an accidental ... be very advantageous. This type of rider provides benefits if ... can be considered a lesser form of life insurance. ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... The University HealthSystem Consortium (UHC) introduced the Tactics ... center to help its academic medical center members ... challenges of the current economic conditions have increased ... cost reduction initiatives and ideas. UHC,s Tactics ...
... had deficient levels, study shows , , WEDNESDAY, April 29 (HealthDay ... ill patients, new research shows. , In a small study, ... intensive care unit were deficient in vitamin D. , "Vitamin ... patients," said study author Dr. Paul Lee, an endocrinologist and ...
... ongoing debate regarding Hormone Replacement Therapy has been raging ... results of a controversial study released in 2002 have ... how to deal with unpleasant menopausal hormone symptoms caused ... and figures such as Oprah Winfrey, Suzanne Somers and ...
... GuidanceST. LOUIS, April 29 Express Scripts, Inc. (Nasdaq: ... operations of $214.7 million, or $0.86 per diluted share, which ... 2008. The Company reported first quarter cash flow from continuing ... year. "It has been a strong start to 2009 ...
... April 29 A drug widely used to treat ... legs syndrome (RLS) and helps people with the disorder get a ... as part of the Late-breaking Science Program at the American Academy ... 2, 2009. RLS affects up to one in ten people.The ...
... dangerous levels of artery-blocking proteins , , WEDNESDAY, April 29 ... artery disease has worked well in a small trial, ... of the protein collagen, which plays a major role ... von zur Muehlen, a fellow in cardiology at University ...
Cached Medicine News:Health News:University HealthSystem Consortium Launches Tactics for Tough Times Initiative to Help Members With Issues Such as Capacity and Medication Management 2Health News:Critically Ill Patients Lack Vitamin D 2Health News:Critically Ill Patients Lack Vitamin D 3Health News:Women's International Pharmacy Offers Free Educational Information About Bioidentical Hormone Replacement Therapy 2Health News:Women's International Pharmacy Offers Free Educational Information About Bioidentical Hormone Replacement Therapy 3Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 2Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 3Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 4Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 5Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 6Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 7Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 8Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 9Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 10Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 11Health News:New Treatment Discovered for Restless Legs Syndrome Improves Sleep 2Health News:Urine Test for Heart Disease Shows Promise 2
... Available in even sizes 20-36F. A ... patient comfort., ,The Latex-Free Robertazzi ... patient comfort while offering the best ... economically priced allowing you to offer ...
Silkolatex™ . Adjustable flange. Single use....
All oral and nasal airways are manufactured with smooth, rounded edges for increased patient comfort and safety., ,Portex® offers a broad selection of airways for a variety of clinical applicati...
Guedel-style enclosed center channel. Semirigid, nontoxic polyethylene with color-coded bite block. Individually packaged, 48 per case. Latex Free....
Medicine Products: